Investigation of a potential food effect on the pharmacokinetics of roflumilast, an oral, once-daily phosphodiesterase 4 inhibitor, in healthy subjects.

Investigation of a potential food effect on the pharmacokinetics of roflumilast, an oral, once-daily phosphodiesterase 4 inhibitor, in healthy subjects.

Item
http://www.wikidata.org/entity/Q51489355
Vulnerable COPD patients with comorbidities: the role of roflumilast.Roflumilast (daliresp): a novel phosphodiesterase-4 inhibitor for the treatment of severe chronic obstructive pulmonary diseaseTreating COPD with PDE 4 inhibitors.Treatment of chronic obstructive pulmonary disease with roflumilast, a new phosphodiesterase 4 inhibitor.Roflumilast: first phosphodiesterase 4 inhibitor approved for treatment of COPD.Update on roflumilast, a phosphodiesterase 4 inhibitor for the treatment of chronic obstructive pulmonary diseasePharmacokinetic evaluation of roflumilast.Roflumilast: a novel treatment for chronic obstructive pulmonary disease.Roflumilast: A Review in COPD.Roflumilast inhibits leukocyte-endothelial cell interactions, expression of adhesion molecules and microvascular permeability.Effect of Food on the Pharmacokinetics of Saroglitazar Magnesium, a Novel Dual PPARαγ Agonist, in Healthy Adult Subjects.Chronopharmacology of roflumilast: a comparative pharmacokinetic study of morning versus evening administration in healthy adults.Roflumilast: systemic therapy for chronic obstructive pulmonary disease.Treatment of obstructive airway diseases with roflumilast, a novel phosphodiesterase 4 inhibitor.Single-dose pharmacokinetics of roflumilast in children and adolescents.Use of a 4-week up-titration regimen of roflumilast in patients with severe COPD.Roflumilast: an oral, once-daily selective PDE-4 inhibitor for the management of COPD and asthma
P2860

Investigation of a potential food effect on the pharmacokinetics of roflumilast, an oral, once-daily phosphodiesterase 4 inhibitor, in healthy subjects.

Item
http://www.wikidata.org/entity/Q51489355
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
Investigation of a potential f ...... nhibitor, in healthy subjects.
@en
Investigation of a potential f ...... nhibitor, in healthy subjects.
@nl
type
label
Investigation of a potential f ...... nhibitor, in healthy subjects.
@en
Investigation of a potential f ...... nhibitor, in healthy subjects.
@nl
prefLabel
Investigation of a potential f ...... nhibitor, in healthy subjects.
@en
Investigation of a potential f ...... nhibitor, in healthy subjects.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P577
P698
P356
P1433
P1476
Investigation of a potential f ...... nhibitor, in healthy subjects.
@en
P2093
P2860
P304
P31
P356
P433
P478
P577
P698